Posts by bethsignify

Chronic hepatitis B – A brief overview March 2022

Chronic hepatitis B

Chronic hepatitis B (CHB) remains a major global healthcare challenge affecting approximately 350 million people, and is a leading cause of chronic liver disease, cirrhosis (liver scarring) and liver cancer. Despite the significant disease burden of CHB, it remains under-diagnosed with research suggesting that as few as 10% of those living with CHB are aware…

Read More

Covid Vaccine Progress

In March of 2020, the WHO declared Covid-19 a pandemic and to date there are still no specific treatments and no licenced vaccines for coronavirus. However, preliminary data released this week from Pfizer suggest significant progress has now been made with highly encouraging results from a Phase 3 study. The interim results from the Pfizer study…

Read More

HBV & Me

I am pleased to announce that my new “HBV & ME” interactive ‘Treatment indicator’ is now available on the website. If you have Chronic Hepatitis B (CHB) my ‘treatment indicator’ will help you better understand and manage your condition.  CHB is a dynamic disease which requires continuous monitoring to determine whether the disease is quiescent…

Read More

Welcome from Dr Kennedy

Dr Patrick Kennedy

Hello and a very warm welcome to my blog. Delivering the highest quality medical care is at the heart of my clinical practice and also drives my academic research in liver disease. Since my appointment as a Senior Lecturer & Consultant at Barts and The London School of Medicine and Dentistry in 2009, I have…

Read More